Literature DB >> 17197083

Phenylephrine and pilocarpine eye drop test for dementia with Lewy bodies and Alzheimer's disease.

Haruo Hanyu1, Kentaro Hirao, Soichiro Shimizu, Hidekazu Kanetaka, Hirofumi Sakurai, Toshihiko Iwamoto.   

Abstract

Pupillary response test using dilute phenylephrine, a sympathetic agonist, and dilute pilocarpine, a cholinergic agonist, were performed in 24 patients with dementia with Lewy bodies (DLB), 40 patients with Alzheimer's disease (AD), and 23 normal elderly subjects. The mydriatic response to 0.5% phenylephrine was significantly greater in the DLB group than in the AD and control groups. The mydriatic change correlated inversely with the reduction in cardiac 123I-metaiodobenzylguanidine uptake. In contrast, miotic response to 0.0625% pilocarpine was significantly greater in the DLB and AD groups than in the control group. The pupil assay using combined phenylephrine and pilocarpine eye drop test may be useful in the detection of patients with DLB and AD and in distinguishing between them.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17197083     DOI: 10.1016/j.neulet.2006.12.015

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

Review 1.  Current and future uses of neuroimaging for cognitively impaired patients.

Authors:  Gary W Small; Susan Y Bookheimer; Paul M Thompson; Greg M Cole; S-C Huang; Vladimir Kepe; Jorge R Barrio
Journal:  Lancet Neurol       Date:  2008-02       Impact factor: 44.182

2.  Drug Repurposing for Alzheimer's Disease Based on Protein-Protein Interaction Network.

Authors:  Negar Sadat Soleimani Zakeri; Saeid Pashazadeh; Habib MotieGhader
Journal:  Biomed Res Int       Date:  2021-10-14       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.